Table 5.
Study | Number of patients | TR prevalence at the end of the followup (%) | Average follow-up period (years) | Definition of significant TR |
---|---|---|---|---|
Current study | n = 163 | 14.1% | 8.2 | ≥mild-moderate |
Chan et al. [3] | n = 336 | 34% | 4.5 | ≥moderate |
Aziz et al. [8] | n = 249 | 53.9% | 5 | ≥moderate |
Hausen et al. [14] | n = 251 | 50% | 4 | ≥moderate-severe |
Williams et al. [18] | n = 72 | 32% | 2.4 | ≥moderate |
Yankah et al. [25] | n = 647 | 5.5% | 5 | ≥moderate |
Chen et al. [27] | n = 178 | 26.4% | 5 | ≥moderate |
Huddleston et al. [28] | n = 183 | 20% | 4 | ≥moderate |
TR: tricuspid regurgitation; OHT: orthotopic heart transplantation.